M3 Overview
- Year Founded
-
2000

- Status
-
Public
- Employees
-
12,100

- Stock Symbol
-
2413

- Investments
-
86
- Share Price
-
$12.69
- (As of Friday Closing)
M3 General Information
Description
M3 Inc is a Japan-based company engaged in providing medical-related services through the use of the Internet. It also supports marketing of pharmaceutical companies and medical equipment manufacturers. The company's business segment includes, Medical Portal segment, Evidence Solution segment, Overseas segment, Clinical Platform segment, Sales Platform segment, and Others. The company generates the majority of its revenue from Medical Portal segment.
Contact Information
Website
corporate.m3.comCorporate Office
- Akasaka Intercity
- 10th Floor, 1-11-44 Akasaka Minato-ku
- Tokyo, 107-0052
- Japan
Corporate Office
- Akasaka Intercity
- 10th Floor, 1-11-44 Akasaka Minato-ku
- Tokyo, 107-0052
- Japan
M3 Stock Performance
As of 18-Apr-2025, M3’s stock price is $12.69. Its current market cap is $8.62B with 679M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$12.69 | $12.38 | $7.74 - $13.66 | $8.62B | 679M | 4.72M | $0.40 |
M3 Financials Summary
As of 31-Dec-2024, M3 has a trailing 12-month revenue of $1.75B.
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 | FY 2022 31-Mar-2022 |
---|---|---|---|---|
EV | 5,057,834 | 8,764,762 | 15,944,109 | 23,916,684 |
Revenue | 1,751,191 | 1,653,286 | 1,704,941 | 1,852,884 |
EBITDA | 507,018 | 586,615 | 902,733 | |
Net Income | 272,047 | 313,316 | 362,146 | 568,303 |
Total Assets | 3,677,890 | 3,242,683 | 3,006,801 | 2,834,795 |
Total Debt | 155,804 | 122,326 | 833 | 85,917 |
M3 Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
M3 Patents
M3 Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
JP-2025022706-A | Media | Pending | 01-Aug-2023 | ||
JP-2025018780-A | Information processing device, information processing method, and program | Pending | 27-Jul-2023 | ||
JP-2024173332-A | Information processing device, information processing method, and program | Pending | 02-Jun-2023 | ||
JP-2024171110-A | Information processing device, information processing method, and program | Pending | 29-May-2023 | ||
JP-2024161676-A | System of producing hydrogen by magnetic processing of saline water | Pending | 08-May-2023 |
M3 Signals
M3 Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
M3 Investments & Acquisitions (86)
M3’s most recent deal was a Merger/Acquisition with Ewel (Other Commercial Services) for
. The deal was made on 05-Mar-2025.Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Ewel (Other Commercial Services) | 05-Mar-2025 | Merger/Acquisition | Other Commercial Services | ||
The Limbic | 25-Feb-2025 | Merger/Acquisition | Publishing | ||
Zest (Enterprise Systems ) | 28-Jan-2025 | Later Stage VC | Enterprise Systems (Healthcare) | ||
MEDIROM MOTHER Labs | 31-Oct-2024 | Early Stage VC | Other Healthcare Technology Systems | ||
Elan 'Matsumoto' | 21-Oct-2024 | Merger/Acquisition | Hospitals/Inpatient Services |
M3 ESG
Risk Overview
Risk Rating
Updated September, 03, 2024
21.16 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,109
Rank
Percentile

Healthcare
Industry
of 587
Rank
Percentile

Health Care IT Services
Subindustry
of 35
Rank
Percentile

M3 Exits (10)
M3’s most recent exit was on 19-Sep-2023 from Alt (Business/Productivity Software). The exit was categorized as with 24 buyers.
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Alt (Business/Productivity Software) | 19-Sep-2023 | Completed |
|
||
Veritas In Silico | 24-Dec-2021 | Completed |
|
||
Visionary Holdings | 17-Feb-2020 | Completed |
|
||
Empheal | 01-Apr-2019 | Completed |
|
||
StemRIM | 28-Dec-2018 | Later Stage VC | Completed |
|
M3 Affiliates
Subsidiaries (28)
Name | Industry | Location | Year Founded |
---|---|---|---|
Messly | London, United Kingdom | 2016 | |
Medcare | Tokyo, Japan | 2015 | |
CUC Inc | Tokyo, Japan | 2014 | |
The Limbic | Sydney, Australia | 2014 | |
DailyRounds | Bangalore, India | 2013 |
M3 FAQs
-
When was M3 founded?
M3 was founded in 2000.
-
Where is M3 headquartered?
M3 is headquartered in Tokyo, Japan.
-
What is the size of M3?
M3 has 12,100 total employees.
-
What industry is M3 in?
M3’s primary industry is Other Healthcare Technology Systems.
-
Is M3 a private or public company?
M3 is a Public company.
-
What is M3’s stock symbol?
The ticker symbol for M3 is 2413.
-
What is the current stock price of M3?
As of 18-Apr-2025 the stock price of M3 is $12.69.
-
What is the current market cap of M3?
The current market capitalization of M3 is $8.62B.
-
What is M3’s current revenue?
The trailing twelve month revenue for M3 is $1.75B.
-
What is M3’s annual earnings per share (EPS)?
M3’s EPS for 12 months was $0.40.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »